Sacituzumab govitecan in heavily pretreated, platinum-resistant high grade serous ovarian cancer

• Asıl Yazarlar: Michelle Greenman (Yazar), Stefania Bellone (Yazar), Cem Demirkiran (Yazar), Tobias Max Philipp Hartwich (Yazar), Alessandro D. Santin (Yazar)
• Materyal Türü: Kitap
• Baskı/Yayın Bilgisi: Elsevier, 2024-08-01T00:00:00Z.
• Konular: article
• Online Erişim: Connect to this object online.

Background: Treatment of recurrent platinum-resistant high grade serous ovarian cancer (HGSOC) remains a challenge. Novel treatment options for recurrent disease are an unmet need. Case: A 69-year-old with recurrent, metastatic, platinum-resistant HGSOC overexpressing TROP2 experienced a significant...